CORCEPT THERAPEUTICS I
58.60
27-November-24 16:45:00
15 minutes delayed
Stocks
+0.02
+0.03%
Today's range
57.84 - 59.21
ISIN
N/A
Source
NASDAQ
-
22 Jul 2024 16:05:00 By Nasdaq GlobeNewswire
-
24 Jun 2024 16:15:00 By Nasdaq GlobeNewswire
-
NetDania - New 12 months High: CORCEPT THERAPEUTICS INCORPORATED - COMMON STOCK
06 Jun 2024 09:45:18 By NetDania Notify
-
NetDania - New 12 months High: CORCEPT THERAPEUTICS INCORPORATED - COMMON STOCK
05 Jun 2024 13:50:40 By NetDania Notify
-
03 Jun 2024 08:00:00 By Nasdaq GlobeNewswire
-
28 May 2024 08:00:00 By Nasdaq GlobeNewswire
-
Corcept Therapeutics Announces First Quarter Financial Results and Provides Corporate Update
01 May 2024 16:05:00 By Nasdaq GlobeNewswire
-
Corcept Completes Enrollment in Phase 4 CATALYST Trial
29 Apr 2024 08:00:00 By Nasdaq GlobeNewswire
-
24 Apr 2024 16:05:00 By Nasdaq GlobeNewswire
-
NetDania - New 12 months Low: CORCEPT THERAPEUTICS INCORPORATED - COMMON STOCK
22 Apr 2024 09:59:41 By NetDania Notify
-
22 Apr 2024 08:00:00 By Nasdaq GlobeNewswire
-
15 Apr 2024 08:00:00 By Nasdaq GlobeNewswire
-
08 Apr 2024 08:00:00 By Nasdaq GlobeNewswire
-
01 Apr 2024 08:00:00 By Nasdaq GlobeNewswire
-
15 Feb 2024 16:07:00 By Nasdaq GlobeNewswire
-
Corcept Announces Preliminary Results From Prevalence Phase Of CATALYST Clinical Trial
15 Feb 2024 16:02:00 By Nasdaq GlobeNewswire
-
08 Feb 2024 16:05:00 By Nasdaq GlobeNewswire
-
Corcept Appoints Roberto Vieira as President, Oncology
29 Jan 2024 08:00:00 By Nasdaq GlobeNewswire
-
Corcept Therapeutics Provides Financial Update and Announces Stock Repurchase Program
08 Jan 2024 08:00:01 By Nasdaq GlobeNewswire
-
Court Finds Corcept Therapeutics’ Patents Not Infringed
02 Jan 2024 08:00:00 By Nasdaq GlobeNewswire